The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
December 26th 2024
From groundbreaking therapies to ethical dilemmas, HCPLive’s top podcasts of 2024 delivered expert insights and human stories across medicine.
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Polypill Worked in Study, FDA Evaluating Concept
Public health researchers have long believed that if patients could take one pill instead of several they would be more likely to comply with the drug regimens prescribed by their physicians. The US Food and Drug Administration's cardiovascular and renal drugs advisory committee is evaluating the "potential clinical utility" of a single pill that would contain an anti-hypertensive drug, aspirin, and a statin. The goal would be to prevent strokes and heart attacks in patients with a history of cardiovascular disease.
New Statin Guidelines Better at Finding Right Patients for Medication
A study finds that new national guidelines can improve the way statins are prescribed to patients at risk for cardiovascular disease, and produce only a modest increase in the number of patients being given the medication.
Review Finds Little Evidence to Link Testosterone Therapy and Increased Cardiovascular Risk
Staff scientists at the US Food and Drug Administration (FDA) have concluded that there's no "convincing evidence" linking testosterone replacement therapy with adverse cardiovascular events.
Study Challenges Guidelines on Treating Heart Artery Lesions
Contrary to the recommendations of the American Heart Association, the American College of Cardiology, and the European Society of Cardiology (ESC), a UK study found it pays to treat more than the lesions in the "culprit" artery after a heart attack.
Hypertension has long been linked to obesity, but a new study shows that where that fat is matters. A team of researchers at University of Texas Southwestern Medical Center in Dallas, TX conclude that when that fat is in the viscera-as opposed to accumulating under the skin-there is a strong chance patients will develop hypertension.
Study Heralds Ticagrelor Use in 911 Care
AstraZeneca's beleaguered anti-platelet drug ticagrelor (Brilinta) may get a boost from a French study published online Sept. 3 in the New England Journal of Medicine. In findings also reported at the European Society of Cardiology Congress in Barcelona, Spain, Gilles Montalescot, MD, found that in a group of 1862 patients, the drug appeared to offer greater protection from stent thrombosis when administered by ambulance personnel than when given later in a cardiac cath lab.
Stage 2 Deadline Rapidly Approaching
The end of September will mark the deadline set for hospitals across the country to reach Stage 2 of the Meaningful Use program for the year and that means the clock is ticking for health care professionals around the country to meet the goals set for them.
Investigational Heart Failure Drug LCZ696 Gets Glowing Reviews
Novartis plans to soon file a new drug application with the US Food and Drug Administration (FDA) for its investigational heart failure drug LCZ696. A report showing the drug works better than enalapril to prevent adverse cardiac events was released at the European Society of Cardiology Congress in Barcelona, Spain Aug. 30 and published online in the New England Journal of Medicine (NEJM).
VBLOCK Shows Success with Diabetes, Hypertension and Weight Loss
A 3-year study of a product meant to help patients dealing with a wide range of conditions including diabetes, hypertension, and weight loss showed positive results according to manufacturer EnteroMedics, Inc.
Coronary Artery Bypass Graft Survives Pay-for-Performance
As the nation tries to cut its health-care costs critics of reform have worried that some patients who need expensive though risky procedures like coronary artery bypass graft surgery might not get them. But a new Harvard School of Public Health study could allay those fears.
US Deaths, Hospitalizations for Heart Disease and Stroke Fell Dramatically
Over the past decade, lifestyle changes, better treatment and effective preventive measures have led to a dramatic decrease in deaths and hospitalizations from heart disease in the United States.
Monitoring Pulse Post-Stroke Can Help Patients Detect Potential Atrial Fibrillation
New research suggests that most patients who have suffered a stroke can be taught to reliably detect the first signs of atrial fibrillation by measuring their peripheral pulse at the radial artery.